<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04320095</url>
  </required_header>
  <id_info>
    <org_study_id>REB19-0088</org_study_id>
    <nct_id>NCT04320095</nct_id>
  </id_info>
  <brief_title>Tonsillectomy Using BiZact Tonsilletomy Device</brief_title>
  <official_title>BiZact Versus Electrocautery in Tonsillectomy: A Single-Center Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Calgary</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Calgary</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to describe how Bizact Tonsillectomy Device might affect
      operative time and intraoperative blood loss in pediatric patients undergoing tonsillectomy,
      and compare these parameters to the standard technique in tonsillectomy at our institution,
      which is electrocautery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      It is a prospective, interventional, single-center study on the performance of Bizact
      tonsillectomy device on children undergoing tonsillectomy.The required parameters concerning
      operative time and intra operative blood loss will be obtained during the procedure.There
      will be no extra clinical visits for the participants.

      Operative time will be assessed in 2 ways: 1). By using blade-tipped electrocautery on one
      tonsil and the BiZact device on the other tonsil for same patient; and 2). using
      electrocautery for removal of both tonsils and comparing the operative time to an equal
      number of cases wherein the BiZact device was used for removal of both tonsils.

      With regard to intra operative bleeding, it will be quantified into one of 3 groups: 1). No
      blood in suction tubing, 2). blood in suction tubing but not in the suction canister, and 3).
      blood in the suction canister.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2020</start_date>
  <completion_date type="Anticipated">February 2021</completion_date>
  <primary_completion_date type="Anticipated">February 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Operative time</measure>
    <time_frame>during the procedure</time_frame>
    <description>The study will be considered success if the mean intra operative time using Bizact device is less than that using electrocautery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intraoperative blood loss</measure>
    <time_frame>during the procedure</time_frame>
    <description>The study will be considered success if the mean intraoperative blood loss using Bizact is less than Electrocautery</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Tonsillectomy</condition>
  <arm_group>
    <arm_group_label>Bizact device for one tonsil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bizact tonsillecotmy device which is an advanced bipolar device using radiofrequency and pressure to ligate the encountered vessels during tonsillectomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Electrocautery for second tonsil</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Electrocautery is the standard technique used at our institution.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bizact device for both tonsils</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consecutive cases of tonsillectomy will be done using Bizact device and compare the operative time collectively for those cases and compare it to same number of cases done using the standard procedure ( Electrocautery)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Electrocautery for both tonsils</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>As explained on the above arm description</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bizact tonsillectomy device</intervention_name>
    <description>Bizact tonsillectomy device is an advanced bipolar instrument that uses radiofrequency energy and pressure to ligate vessels interposed between its jaws. The energy produced by the device is automatically adjusted based on tissue impedance in an attempt to minimize thermal tissue damage.</description>
    <arm_group_label>Bizact device for both tonsils</arm_group_label>
    <arm_group_label>Bizact device for one tonsil</arm_group_label>
    <arm_group_label>Electrocautery for both tonsils</arm_group_label>
    <arm_group_label>Electrocautery for second tonsil</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Children scheduled for tonsillectomy at Alberta Children Hospital

          2. Tonsillectomy for either recurrent tonsillitis or sleep-disordered breathing.

        Exclusion Criteria:

          1. Craniofacial abnormalities

          2. Bleeding disorders

          3. Complex medical background
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Khaloud Al Bahri, MD</last_name>
    <phone>587-888-1284</phone>
    <email>khaloud.albahri@ucalgary.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Warren Yunker, MD, PhD</last_name>
    <email>Warren.Yunker@albertahealthservices.ca</email>
  </overall_contact_backup>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 22, 2020</study_first_submitted>
  <study_first_submitted_qc>March 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 24, 2020</study_first_posted>
  <last_update_submitted>March 30, 2020</last_update_submitted>
  <last_update_submitted_qc>March 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 31, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

